الولايات المتحدة · منصات وبيانات · MarketBeat
ImmuCell Q3 Earnings Call Highlights

ملخص مفصل
ImmuCell (NASDAQ:ICCC) reported a 46% increase in third-quarter product sales and returned to profitability as improved manufacturing output and stronger demand supported its First Defense calf-health products. The company’s unaudited product sales rose to $8 million for the quarter ended Sept. 30,
يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.marketbeat.com)




